End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.12 TWD | +0.05% |
|
+0.14% | -.--% |
2019 | Glac Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
2017 | Glac Biotech Co., Ltd. completed the acquisition of Glory Biotech Co., Ltd.. | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chung Wei Kuo
CEO | Chief Executive Officer | - | 08-08-04 |
Sheng Hung Huang
DFI | Director of Finance/CFO | - | 14-07-06 |
Pei Shan Hsieh
CTO | Chief Tech/Sci/R&D Officer | - | 08-08-04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wan Lai Cheng
BRD | Director/Board Member | - | 08-07-29 |
Chung Liang Li
BRD | Director/Board Member | 71 | - |
Jung Chin Lin
CHM | Chairman | 70 | 08-07-20 |
Chi Hsing Chang
BRD | Director/Board Member | - | 16-03-30 |
Chung Wei Kuo
CEO | Chief Executive Officer | - | 08-08-04 |
Zhong Chuan Shi
BRD | Director/Board Member | - | 16-03-30 |
Han Jia Lin
BRD | Director/Board Member | - | 18-05-13 |
Company contact information
![address glac Biotech Co., Ltd.(6553)](https://cdn.zonebourse.com/static/address/45428602.png)
Sector
- Stock Market
- Equities
- 6553 Stock
- Company glac Biotech Co., Ltd.